Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model

Cancer Cell

Volumn 4, Issue 3, 2003, Pages 181-189

  Meuwissen, Ralph ^a   Linn, Sabine C ^b   Linnoila, R Ilona ^c   Zevenhoven, John ^a   Mooi, Wolter J ^b   Berns, Anton ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CANCER MODEL; CARCINOGENESIS; DISEASE SEVERITY; EPITHELIUM CELL; GENE; GENE FUNCTION; GENE INACTIVATION; IMMUNOPHENOTYPING; LUNG ALVEOLUS EPITHELIUM; LUNG SMALL CELL CANCER; METASTASIS; MORPHOLOGY; MOUSE; NEUROENDOCRINE TUMOR; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RB1 GENE; TRP53 GENE;

ANIMALIA; MURINAE;

EID: 0141523025     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00220-4     Document Type: Article

References (47)

1. Ball D.W., Azzoli C.G., Baylin S.B., Chi D., Dou S., Donis-Keller H., Cumaraswamy A., Borges M., Nelkin B.D. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc. Natl. Acad. Sci. USA. 90:1993;5648-5652.
2. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., Ladd C., Beheshti J., Bueno R., Gillette M.et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA. 98:2001;13790-13795.
3. Borges M., Linnoila R.I., van de Velde H.J., Chen H., Nelkin B.D., Mabry M., Baylin S.B., Ball D.W. An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature. 386:1997;852-855.
4. Brodeur G.M. Neuroblastoma. biological insights into a clinical enigma Nat. Rev. Cancer. 3:2003;203-216.
5. Cavallaro U., Niedermeyer J., Fuxa M., Christofori G. N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling. Nat. Cell Biol. 3:2001;650-657.
6. Classon M., Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer. 2:2002;910-917.
7. Dannenberg J.H., van Rossum A., Schuijff L., te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14:2000;3051-3064.
8. Donehower L.A. The p53-deficient mouse. a model for basic and applied cancer studies Semin. Cancer Biol. 7:1996;269-278.
9. Ferrari L., Seregni E., Bajetta E., Martinetti A., Bombardieri E. The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours. Anticancer Res. 19:1999;3415-3427.
10. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., van de Rijn M., Rosen G.D., Perou C.M., Whyte R.I.et al. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA. 98:2001;13784-13789.
11. Gouyer V., Gazzeri S., Bolon I., Drevet C., Brambilla C., Brambilla E. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors. Am. J. Respir. Cell Mol. Biol. 18:1998;188-196.
12. Ito T., Udaka N., Yazawa T., Okudela K., Hayashi H., Sudo T., Guillemot F., Kageyama R., Kitamura H. Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. Development. 127:2000;3913-3921.
13. Jacks T., Fazeli A., Schmitt E.M., Bronson R.T., Goodell M.A., Weinberg R.A. Effects of an Rb mutation in the mouse. Nature. 359:1992;295-300.
14. Jackson E.L., Willis N., Mercer K., Bronson R.T., Crowley D., Montoya R., Jacks T., Tuveson D.A. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15:2001;3243-3248.
15. Jogi A., Persson P., Grynfeld A., Pahlman S., Axelson H. Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation. J. Biol. Chem. 277:2002;9118-9126.
16. Jonkers J., Meuwissen R., van der Gulden H., Peterse H., van der Valk M., Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29:2001;418-425.
17. Junker K., Wiethege T., Muller K.M. Pathology of small-cell lung cancer. J. Cancer Res. Clin. Oncol. 126:2000;361-368.
18. Kobayashi S., Okada S., Hasumi T., Sato N., Fujimura S. The significance of NSE and CEA as a diffrentiation marker for the cellular heterogeneity of small cell lung cancer. Tohoku J. Exp. Med. 189:1999;37-49.
19. Laird P.W., Zijderveld A., Linders K., Rudnicki M.A., Jaenisch R., Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:1991;4293.
20. Lasorella A., Noseda M., Beyna M., Yokota Y., Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature. 407:2000;592-598.
21. Linnoila R.I., Zhao B., DeMayo J.L., Nelkin B.D., Baylin S.B., DeMayo F.J., Ball D.W. Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice. Cancer Res. 60:2000;4005-4009.
22. Lipinski M.M., Jacks T. The retinoblastoma gene family in differentiation and development. Oncogene. 18:1999;7873-7882.
23. Maandag E.C., van der Valk M., Vlaar M., Feltkamp C., O'Brien J., van Roon M., van der Lugt N., Berns A., te Riele H. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13:1994;4260-4268.
24. Magdaleno S.M., Wang G., Mireles V.L., Ray M.K., Finegold M.J., DeMayo F.J. Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice. Cell Growth Differ. 8:1997;145-155.
25. Marino S., Vooijs M., van Der Gulden H., Jonkers J., Berns A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14:2000;994-1004.
26. Meuwissen R., Linn S.C., van der Valk M., Mooi W.J., Berns A. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene. 20:2001;6551-6558.
27. Minna J.D., Roth J.A., Gazdar A.F. Focus on lung cancer. Cancer Cell. 1:2002;49-52.
28. Ordonez N.G. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am. J. Surg. Pathol. 24:2000;1217-1223.
29. Reynolds S.D., Giangreco A., Power J.H., Stripp B.R. Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am. J. Pathol. 156:2000;269-278. a.
30. Reynolds S.D., Hong K.U., Giangreco A., Mango G.W., Guron C., Morimoto Y., Stripp B.R. Conditional clara cell ablation reveals a self-renewing progenitor function of pulmonary neuroendocrine cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 278:2000;L1256-L1263. b.
31. Rom W.N., Hay J.G., Lee T.C., Jiang Y., Tchou-Wong K.M. Molecular and genetic aspects of lung cancer. Am. J. Respir. Crit. Care Med. 161:2000;1355-1367.
32. Sage J., Mulligan G.J., Attardi L.D., Miller A., Chen S., Williams B., Theodorou E., Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14:2000;3037-3050.
33. Sandler A.B. Chemotherapy for small cell lung cancer. Semin. Oncol. 30:2003;9-25.
34. Sattler M., Salgia R. Molecular and cellular biology of small cell lung cancer. Semin. Oncol. 30:2003;57-71.
35. Sekido Y., Fong K.M., Minna J.D. Molecular genetics of lung cancer. Annu. Rev. Med. 54:2003;73-87.
36. Sherr C.J., McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2:2002;103-112.
37. Shibayama T., Ueoka H., Nishii K., Kiura K., Tabata M., Miyatake K., Kitajima T., Harada M. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). Lung Cancer. 32:2001;61-69.
38. Sunday M.E., Haley K.J., Sikorski K., Graham S.A., Emanuel R.L., Zhang F., Mu Q., Shahsafaei A., Hatzis D. Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms. Oncogene. 18:1999;4336-4347.
39. Toma J.G., El Bizri H., Barnabe-Heider F., Aloyz R., Miller F.D. Evidence that helix-loop-helix proteins collaborate with retinoblastoma tumor suppressor protein to regulate cortical neurogenesis. J. Neurosci. 20:2000;7648-7656.
40. Tyczynski J.E., Bray F., Parkin D.M. Lung cancer in Europe in 2000. epidemiology, prevention, and early detection Lancet Oncol. 4:2003;45-55.
41. Vooijs M., van der Valk M., te Riele H., Berns A. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse. Oncogene. 17:1998;1-12.
42. Watkins D.N., Berman D.M., Burkholder S.G., Wang B., Beachy P.A., Baylin S.B. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature. 422:2003;313-317.
43. Wechsler-Reya R., Scott M.P. The developmental biology of brain tumors. Annu. Rev. Neurosci. 24:2001;385-428.
44. Williams B.O., Remington L., Albert D.M., Mukai S., Bronson R.T., Jacks T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat. Genet. 7:1994;480-484.
45. Wistuba I.I., Gazdar A.F., Minna J.D. Molecular genetics of small cell lung carcinoma. Semin. Oncol. 28:2001;3-13.
46. Wu M., Wang B., Gil J., Sabo E., Miller L., Gan L., Burstein D.E. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am. J. Clin. Pathol. 119:2003;696-702.
47. Wuenschell C.W., Sunday M.E., Singh G., Minoo P., Slavkin H.C., Warburton D. Embryonic mouse lung epithelial progenitor cells co-express immunohistochemical markers of diverse mature cell lineages. J. Histochem. Cytochem. 44:1996;113-123.